Latest INIT II Stories
The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects.
U.S. researchers said on Monday that a daily squirt of insulin through the nose could help improve memory skills in people with Alzheimer's.
Intranasal insulin therapy appears to provide some benefit for cognitive function in patients with amnestic mild cognitive impairment and Alzheimer disease.
A chemical produced by the same cells that make insulin in the pancreas prevented and even reversed Type 1 diabetes in mice, researchers at St. Michaelâ€™s Hospital have found.
A Finnish study confirms the hypothesis that infant feeding plays a role in the initiation of the disease process leading to type 1 diabetes in children carrying increased genetic disease risk.
New Zealand-based biotech company Living Cell Technologies has launched an experiment that will place pig cells into eight volunteer participants.
Scientists believe they may have found a preventative therapy for Type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.
CAMBRIDGE, Mass., Aug.
- A poem in which the author retracts something said in an earlier poem.